![Medicinova Inc](/common/images/company/N_MNOV.png)
MediciNova Inc is a biopharmaceutical company. The company acquires and develops small-molecule therapeutics for the treatment of diseases with unmet medical needs with a specific focus on the U.S. market. Its products portfolio includes therapeutics such as MN-001, MN-166, MN-221 etc. The firm's cu... MediciNova Inc is a biopharmaceutical company. The company acquires and develops small-molecule therapeutics for the treatment of diseases with unmet medical needs with a specific focus on the U.S. market. Its products portfolio includes therapeutics such as MN-001, MN-166, MN-221 etc. The firm's current strategy is to focus its development activities on therapeutics for neurological disorders and fibrotic diseases. It has the acquisition and development of the small molecule therapeutics segments. Show more
Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0.07 | 3.68421052632 | 1.9 | 1.97 | 1.8202 | 15071 | 1.85351107 | CS |
4 | 0.01 | 0.510204081633 | 1.96 | 2.06 | 1.79 | 17169 | 1.91056604 | CS |
12 | -0.0295 | -1.47536884221 | 1.9995 | 2.48 | 1.79 | 35098 | 2.11182832 | CS |
26 | 0.83 | 72.8070175439 | 1.14 | 2.55 | 1.13 | 55964 | 2.01543879 | CS |
52 | 0.66 | 50.3816793893 | 1.31 | 2.55 | 1.12 | 45371 | 1.77427902 | CS |
156 | -0.46 | -18.9300411523 | 2.43 | 3.18 | 1.12 | 45911 | 2.0472111 | CS |
260 | -4.07 | -67.3841059603 | 6.04 | 13.25 | 1.12 | 275411 | 6.37505876 | CS |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales